{"pmid":32442756,"title":"Combination of four clinical indicators predicts the severe/critical symptom of patients infected COVID-19.","text":["Combination of four clinical indicators predicts the severe/critical symptom of patients infected COVID-19.","BACKGROUND: Despite the death rate of COVID-19 is less than 3%, the fatality rate of severe/critical cases is high, according to World Health Organization (WHO). Thus, screening the severe/critical cases before symptom occurs effectively saves medical resources. METHODS AND MATERIALS: In this study, all 336 cases of patients infected COVID-19 in Shanghai to March 12th, were retrospectively enrolled, and divided in to training and test datasets. In addition, 220 clinical and laboratory observations/records were also collected. Clinical indicators were associated with severe/critical symptoms were identified and a model for severe/critical symptom prediction was developed. RESULTS: Totally, 36 clinical indicators significantly associated with severe/critical symptom were identified. The clinical indicators are mainly thyroxine, immune related cells and products. Support Vector Machine (SVM) and optimized combination of age, GSH, CD3 ratio and total protein has a good performance in discriminating the mild and severe/critical cases. The area under receiving operating curve (AUROC) reached 0.9996 and 0.9757 in the training and testing dataset, respectively. When the using cut-off value as 0.0667, the recall rate was 93.33 % and 100 % in the training and testing datasets, separately. Cox multivariate regression and survival analyses revealed that the model significantly discriminated the severe/critical cases and used the information of the selected clinical indicators. CONCLUSION: The model was robust and effective in predicting the severe/critical COVID cases.","J Clin Virol","Sun, Liping","Song, Fengxiang","Shi, Nannan","Liu, Fengjun","Li, Shenyang","Li, Ping","Zhang, Weihan","Jiang, Xiao","Zhang, Yongbin","Sun, Lining","Chen, Xiong","Shi, Yuxin","32442756"],"abstract":["BACKGROUND: Despite the death rate of COVID-19 is less than 3%, the fatality rate of severe/critical cases is high, according to World Health Organization (WHO). Thus, screening the severe/critical cases before symptom occurs effectively saves medical resources. METHODS AND MATERIALS: In this study, all 336 cases of patients infected COVID-19 in Shanghai to March 12th, were retrospectively enrolled, and divided in to training and test datasets. In addition, 220 clinical and laboratory observations/records were also collected. Clinical indicators were associated with severe/critical symptoms were identified and a model for severe/critical symptom prediction was developed. RESULTS: Totally, 36 clinical indicators significantly associated with severe/critical symptom were identified. The clinical indicators are mainly thyroxine, immune related cells and products. Support Vector Machine (SVM) and optimized combination of age, GSH, CD3 ratio and total protein has a good performance in discriminating the mild and severe/critical cases. The area under receiving operating curve (AUROC) reached 0.9996 and 0.9757 in the training and testing dataset, respectively. When the using cut-off value as 0.0667, the recall rate was 93.33 % and 100 % in the training and testing datasets, separately. Cox multivariate regression and survival analyses revealed that the model significantly discriminated the severe/critical cases and used the information of the selected clinical indicators. CONCLUSION: The model was robust and effective in predicting the severe/critical COVID cases."],"journal":"J Clin Virol","authors":["Sun, Liping","Song, Fengxiang","Shi, Nannan","Liu, Fengjun","Li, Shenyang","Li, Ping","Zhang, Weihan","Jiang, Xiao","Zhang, Yongbin","Sun, Lining","Chen, Xiong","Shi, Yuxin"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32442756","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.jcv.2020.104431","keywords":["covid-19","prediction","svm","critical/severe symptom"],"locations":["Shanghai"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1667523504852959233,"score":9.490897,"similar":[{"pmid":32405253,"pmcid":"PMC7219384","title":"Combination of four clinical indicators predicts the severe/critical symptom of patients infected COVID-19.","text":["Combination of four clinical indicators predicts the severe/critical symptom of patients infected COVID-19.","Background: Despite the death rate of COVID-19 is less than 3%, the fatality rate of severe/critical cases is high, according to World Health Organization (WHO). Thus, screening the severe/critical cases before symptom occurs effectively saves medical resources. Methods and materials: In this study, all 336 cases of patients infected COVID-19 in Shanghai to March 12(th), were retrospectively enrolled, and divided in to training and test datasets. In addition, 220 clinical and laboratory observations/records were also collected. Clinical indicators were associated with severe/critical symptoms were identified and a model for severe/critical symptom prediction was developed. Results: Totally, 36 clinical indicators significantly associated with severe/critical symptom were identified. The clinical indicators are mainly thyroxine, immune related cells and products. Support Vector Machine (SVM) and optimized combination of age, GSH, CD3 ratio and total protein has a good performance in discriminating the mild and severe/critical cases. The area under receiving operating curve (AUROC) reached 0.9996 and 0.9757 in the training and testing dataset, respectively. When the using cut-off value as 0.0667, the recall rate was 93.33% and 100% in the training and testing datasets, separately. Cox multivariate regression and survival analyses revealed that the model significantly discriminated the severe/critical cases and used the information of the selected clinical indicators. Conclusion: The model was robust and effective in predicting the severe/critical COVID cases.","J Clin Virol","Sun, Liping","Liu, Gang","Song, Fengxiang","Shi, Nannan","Liu, Fengjun","Li, Shenyang","Li, Ping","Zhang, Weihan","Jiang, Xiao","Zhang, Yongbin","Sun, Lining","Chen, Xiong","Shi, Yuxin","32405253"],"abstract":["Background: Despite the death rate of COVID-19 is less than 3%, the fatality rate of severe/critical cases is high, according to World Health Organization (WHO). Thus, screening the severe/critical cases before symptom occurs effectively saves medical resources. Methods and materials: In this study, all 336 cases of patients infected COVID-19 in Shanghai to March 12(th), were retrospectively enrolled, and divided in to training and test datasets. In addition, 220 clinical and laboratory observations/records were also collected. Clinical indicators were associated with severe/critical symptoms were identified and a model for severe/critical symptom prediction was developed. Results: Totally, 36 clinical indicators significantly associated with severe/critical symptom were identified. The clinical indicators are mainly thyroxine, immune related cells and products. Support Vector Machine (SVM) and optimized combination of age, GSH, CD3 ratio and total protein has a good performance in discriminating the mild and severe/critical cases. The area under receiving operating curve (AUROC) reached 0.9996 and 0.9757 in the training and testing dataset, respectively. When the using cut-off value as 0.0667, the recall rate was 93.33% and 100% in the training and testing datasets, separately. Cox multivariate regression and survival analyses revealed that the model significantly discriminated the severe/critical cases and used the information of the selected clinical indicators. Conclusion: The model was robust and effective in predicting the severe/critical COVID cases."],"journal":"J Clin Virol","authors":["Sun, Liping","Liu, Gang","Song, Fengxiang","Shi, Nannan","Liu, Fengjun","Li, Shenyang","Li, Ping","Zhang, Weihan","Jiang, Xiao","Zhang, Yongbin","Sun, Lining","Chen, Xiong","Shi, Yuxin"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32405253","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.jcv.2020.104431","keywords":["covid-19","svm","critical/severe symptom","prediction"],"locations":["Shanghai"],"countries":["China"],"countries_codes":["CHN|China"],"e_drugs":["Thyroxine"],"topics":["Diagnosis"],"weight":1,"_version_":1666802845557456896,"score":936.6381},{"pmid":32304402,"pmcid":"PMC7173027","title":"The performance of chest CT in evaluating the clinical severity of COVID-19 pneumonia: identifying critical cases based on CT characteristics.","text":["The performance of chest CT in evaluating the clinical severity of COVID-19 pneumonia: identifying critical cases based on CT characteristics.","OBJECTIVES: To assess the clinical severity of COVID-19 pneumonia using qualitative and/or quantitative chest CT indicators and identify the CT characteristics of critical cases. MATERIALS AND METHODS: Fifty-one patients with COVID-19 pneumonia including ordinary cases (group A, n=12), severe cases(group B, n=15) and critical cases (group C, n=24) were retrospectively enrolled. The qualitative and quantitative indicators from chest CT were recorded and compared using Fisher's exact test, one-way ANOVA, Kruskal-Wallis H test and receiver operating characteristic analysis. RESULTS: Depending on the severity of the disease, the number of involved lung segments and lobes, the frequencies of consolidation, crazy-paving pattern and air bronchogram increased in more severe cases. Qualitative indicators including total severity score for the whole lung and total score for crazy-paving and consolidation could distinguish groups B and C from A(69% sensitivity, 83% specificity and 73% accuracy) but were similar between group B and group C. Combined qualitative and quantitative indicators could distinguish these three groups with high sensitivity(B+C vs. A, 90%; C vs. B, 92%), specificity(100%, 87%) and accuracy(92%, 90%). Critical cases had higher total severity score(>10) and higher total score for crazy-paving and consolidation(>4) than ordinary cases, and had higher mean lung density(>-779HU) and full width at half maximum(>128HU) but lower relative volume of normal lung density(<==50%) than ordinary/severe cases. In our critical cases, eight patients with relative volume of normal lung density smaller than 40% received mechanical ventilation for supportive treatment, and two of them had died. CONCLUSION: A rapid, accurate severity assessment of COVID-19 pneumonia based on chest CT would be feasible and could provide help for making management decisions, especially for the critical cases.","Invest Radiol","Lyu, Peijie","Liu, Xing","Zhang, Rui","Shi, Lei","Gao, Jianbo","32304402"],"abstract":["OBJECTIVES: To assess the clinical severity of COVID-19 pneumonia using qualitative and/or quantitative chest CT indicators and identify the CT characteristics of critical cases. MATERIALS AND METHODS: Fifty-one patients with COVID-19 pneumonia including ordinary cases (group A, n=12), severe cases(group B, n=15) and critical cases (group C, n=24) were retrospectively enrolled. The qualitative and quantitative indicators from chest CT were recorded and compared using Fisher's exact test, one-way ANOVA, Kruskal-Wallis H test and receiver operating characteristic analysis. RESULTS: Depending on the severity of the disease, the number of involved lung segments and lobes, the frequencies of consolidation, crazy-paving pattern and air bronchogram increased in more severe cases. Qualitative indicators including total severity score for the whole lung and total score for crazy-paving and consolidation could distinguish groups B and C from A(69% sensitivity, 83% specificity and 73% accuracy) but were similar between group B and group C. Combined qualitative and quantitative indicators could distinguish these three groups with high sensitivity(B+C vs. A, 90%; C vs. B, 92%), specificity(100%, 87%) and accuracy(92%, 90%). Critical cases had higher total severity score(>10) and higher total score for crazy-paving and consolidation(>4) than ordinary cases, and had higher mean lung density(>-779HU) and full width at half maximum(>128HU) but lower relative volume of normal lung density(<==50%) than ordinary/severe cases. In our critical cases, eight patients with relative volume of normal lung density smaller than 40% received mechanical ventilation for supportive treatment, and two of them had died. CONCLUSION: A rapid, accurate severity assessment of COVID-19 pneumonia based on chest CT would be feasible and could provide help for making management decisions, especially for the critical cases."],"journal":"Invest Radiol","authors":["Lyu, Peijie","Liu, Xing","Zhang, Rui","Shi, Lei","Gao, Jianbo"],"date":"2020-04-19T11:00:00Z","year":2020,"_id":"32304402","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1097/RLI.0000000000000689","topics":["Diagnosis"],"weight":1,"_version_":1666138491115798530,"score":201.29486},{"pmid":32118615,"pmcid":"PMC7147273","title":"The Clinical and Chest CT Features Associated With Severe and Critical COVID-19 Pneumonia.","text":["The Clinical and Chest CT Features Associated With Severe and Critical COVID-19 Pneumonia.","OBJECTIVE: The aim of this study was to investigate the clinical and computed tomography (CT) features associated with severe and critical coronavirus disease 2019 (COVID-19) pneumonia. MATERIALS AND METHODS: Eighty-three patients with COVID-19 pneumonia including 25 severe/critical cases and 58 ordinary cases were enrolled. The chest CT images and clinical data of them were reviewed and compared. The risk factors associated with disease severity were analyzed. RESULTS: Compared with the ordinary patients, the severe/critical patients had older ages, higher incidence of comorbidities, cough, expectoration, chest pain, and dyspnea. The incidences of consolidation, linear opacities, crazy-paving pattern, and bronchial wall thickening in severe/critical patients were significantly higher than those of the ordinary patients. Besides, severe/critical patients showed higher incidences of lymph node enlargement, pericardial effusion, and pleural effusion than the ordinary patients. The CT scores of severe/critical patients were significantly higher than those of the ordinary patients (P < 0.001). Receiver operating characteristic curve showed that the sensitivity and specificity of CT score were 80.0% and 82.8%, respectively, for the discrimination of the 2 types. The clinical factors of age older than 50 years, comorbidities, dyspnea, chest pain, cough, expectoration, decreased lymphocytes, and increased inflammation indicators were risk factors for severe/critical COVID-19 pneumonia. Computed tomography findings of consolidation, linear opacities, crazy-paving pattern, bronchial wall thickening, high CT scores, and extrapulmonary lesions were features of severe/critical COVID-19 pneumonia. CONCLUSIONS: There are significant differences in clinical symptoms, laboratory examinations, and CT manifestations between the ordinary patients and the severe/critical patients. Many factors are related to the severity of the disease, which can help clinicians to judge the severity of the patient and evaluate the prognosis.","Invest Radiol","Li, Kunhua","Wu, Jiong","Wu, Faqi","Guo, Dajing","Chen, Linli","Fang, Zheng","Li, Chuanming","32118615"],"abstract":["OBJECTIVE: The aim of this study was to investigate the clinical and computed tomography (CT) features associated with severe and critical coronavirus disease 2019 (COVID-19) pneumonia. MATERIALS AND METHODS: Eighty-three patients with COVID-19 pneumonia including 25 severe/critical cases and 58 ordinary cases were enrolled. The chest CT images and clinical data of them were reviewed and compared. The risk factors associated with disease severity were analyzed. RESULTS: Compared with the ordinary patients, the severe/critical patients had older ages, higher incidence of comorbidities, cough, expectoration, chest pain, and dyspnea. The incidences of consolidation, linear opacities, crazy-paving pattern, and bronchial wall thickening in severe/critical patients were significantly higher than those of the ordinary patients. Besides, severe/critical patients showed higher incidences of lymph node enlargement, pericardial effusion, and pleural effusion than the ordinary patients. The CT scores of severe/critical patients were significantly higher than those of the ordinary patients (P < 0.001). Receiver operating characteristic curve showed that the sensitivity and specificity of CT score were 80.0% and 82.8%, respectively, for the discrimination of the 2 types. The clinical factors of age older than 50 years, comorbidities, dyspnea, chest pain, cough, expectoration, decreased lymphocytes, and increased inflammation indicators were risk factors for severe/critical COVID-19 pneumonia. Computed tomography findings of consolidation, linear opacities, crazy-paving pattern, bronchial wall thickening, high CT scores, and extrapulmonary lesions were features of severe/critical COVID-19 pneumonia. CONCLUSIONS: There are significant differences in clinical symptoms, laboratory examinations, and CT manifestations between the ordinary patients and the severe/critical patients. Many factors are related to the severity of the disease, which can help clinicians to judge the severity of the patient and evaluate the prognosis."],"journal":"Invest Radiol","authors":["Li, Kunhua","Wu, Jiong","Wu, Faqi","Guo, Dajing","Chen, Linli","Fang, Zheng","Li, Chuanming"],"date":"2020-03-03T11:00:00Z","year":2020,"_id":"32118615","source":"PubMed","week":"202010|Mar 02 - Mar 08","doi":"10.1097/RLI.0000000000000672","topics":["Diagnosis","Mechanism"],"weight":1,"_version_":1666138490748796928,"score":192.34026},{"pmid":32367888,"title":"COVID-19 Dynamic Computed Tomography (CT) Performance and Observation of Some Laboratory Indicators.","text":["COVID-19 Dynamic Computed Tomography (CT) Performance and Observation of Some Laboratory Indicators.","BACKGROUND Chest CT has an essential role in the detection and evaluation of novel coronary pneumonia (COVID-19) and has be regarded as a critical supplement for RT-PCR. This study explored the dynamic CT manifestations of COVID-19 at different times and the value of some laboratory indicators for clinical guidance. MATERIAL AND METHODS This retrospective review included 44 patients who were infected with COVID-19. The dynamic chest CT and laboratory findings were obtained from electronic medical records. The intervals between onset and CT scans and the dynamic changes of the lesions were recorded. The above data were reviewed, sorted, and analyzed by using SPSS 21.0 software. RESULTS From the time of onset, the dynamic image of the lungs became more complete. Fibrous cord shadow absorption in the lungs were observed. Experimental indicators, biochemical indicators of lymphocytes, and protein series were decreased to varying degrees, while erythrocyte sedimentation, fibrinogen, and D-dimer were increased to varying degrees. CONCLUSIONS The dynamic changes of CT images of lungs of COVID-19 patients, combined with the clinical manifestations and laboratory indicators of patients, can help guide clinical diagnosis and treatment.","Med Sci Monit","Jiang, Xiangsen","Yin, Zudong","Wang, Tao","Zhai, Nailiang","Lu, Feng","Zhan, Chunhua","Han, Qizheng","Feng, Changjiang","32367888"],"abstract":["BACKGROUND Chest CT has an essential role in the detection and evaluation of novel coronary pneumonia (COVID-19) and has be regarded as a critical supplement for RT-PCR. This study explored the dynamic CT manifestations of COVID-19 at different times and the value of some laboratory indicators for clinical guidance. MATERIAL AND METHODS This retrospective review included 44 patients who were infected with COVID-19. The dynamic chest CT and laboratory findings were obtained from electronic medical records. The intervals between onset and CT scans and the dynamic changes of the lesions were recorded. The above data were reviewed, sorted, and analyzed by using SPSS 21.0 software. RESULTS From the time of onset, the dynamic image of the lungs became more complete. Fibrous cord shadow absorption in the lungs were observed. Experimental indicators, biochemical indicators of lymphocytes, and protein series were decreased to varying degrees, while erythrocyte sedimentation, fibrinogen, and D-dimer were increased to varying degrees. CONCLUSIONS The dynamic changes of CT images of lungs of COVID-19 patients, combined with the clinical manifestations and laboratory indicators of patients, can help guide clinical diagnosis and treatment."],"journal":"Med Sci Monit","authors":["Jiang, Xiangsen","Yin, Zudong","Wang, Tao","Zhai, Nailiang","Lu, Feng","Zhan, Chunhua","Han, Qizheng","Feng, Changjiang"],"date":"2020-05-06T11:00:00Z","year":2020,"_id":"32367888","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.12659/MSM.924403","topics":["Diagnosis"],"weight":1,"_version_":1666138496235995138,"score":186.71935},{"pmid":32281668,"title":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early.","text":["C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early.","COVID-19 has developed into a worldwide pandemic; early identification of severe illness is critical for controlling it and improving the prognosis of patients with limited medical resources. The present study aimed to analyze the characteristics of severe COVID-19 and identify biomarkers for differential diagnosis and prognosis prediction. In total, 27 consecutive patients with COVID-19 and 75 patients with flu were retrospectively enrolled. Clinical parameters were collected from electronic medical records. The disease course was divided into four stages: initial, progression, peak, and recovery stages, according to computed tomography (CT) progress. to mild COVID-19, the lymphocytes in the severe COVID-19 progressively decreased at the progression and the peak stages, but rebound in the recovery stage. The levels of C-reactive protein (CRP) in the severe group at the initial and progression stages were higher than those in the mild group. Correlation analysis showed that CRP (R = .62; P < .01), erythrocyte sedimentation rate (R = .55; P < .01) and granulocyte/lymphocyte ratio (R = .49; P < .01) were positively associated with the CT severity scores. In contrast, the number of lymphocytes (R = -.37; P < .01) was negatively correlated with the CT severity scores. The receiver-operating characteristic analysis demonstrated that area under the curve of CRP on the first visit for predicting severe COVID-19 was 0.87 (95% CI 0.10-1.00) at 20.42 mg/L cut-off, with sensitivity and specificity 83% and 91%, respectively. CRP in severe COVID-19 patients increased significantly at the initial stage, before CT findings. Importantly, CRP, which was associated with disease development, predicted early severe COVID-19.","J Med Virol","Tan, Chaochao","Huang, Ying","Shi, Fengxia","Tan, Kui","Ma, Qionghui","Chen, Yong","Jiang, Xixin","Li, Xiaosong","32281668"],"abstract":["COVID-19 has developed into a worldwide pandemic; early identification of severe illness is critical for controlling it and improving the prognosis of patients with limited medical resources. The present study aimed to analyze the characteristics of severe COVID-19 and identify biomarkers for differential diagnosis and prognosis prediction. In total, 27 consecutive patients with COVID-19 and 75 patients with flu were retrospectively enrolled. Clinical parameters were collected from electronic medical records. The disease course was divided into four stages: initial, progression, peak, and recovery stages, according to computed tomography (CT) progress. to mild COVID-19, the lymphocytes in the severe COVID-19 progressively decreased at the progression and the peak stages, but rebound in the recovery stage. The levels of C-reactive protein (CRP) in the severe group at the initial and progression stages were higher than those in the mild group. Correlation analysis showed that CRP (R = .62; P < .01), erythrocyte sedimentation rate (R = .55; P < .01) and granulocyte/lymphocyte ratio (R = .49; P < .01) were positively associated with the CT severity scores. In contrast, the number of lymphocytes (R = -.37; P < .01) was negatively correlated with the CT severity scores. The receiver-operating characteristic analysis demonstrated that area under the curve of CRP on the first visit for predicting severe COVID-19 was 0.87 (95% CI 0.10-1.00) at 20.42 mg/L cut-off, with sensitivity and specificity 83% and 91%, respectively. CRP in severe COVID-19 patients increased significantly at the initial stage, before CT findings. Importantly, CRP, which was associated with disease development, predicted early severe COVID-19."],"journal":"J Med Virol","authors":["Tan, Chaochao","Huang, Ying","Shi, Fengxia","Tan, Kui","Ma, Qionghui","Chen, Yong","Jiang, Xixin","Li, Xiaosong"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32281668","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1002/jmv.25871","keywords":["c-reactive protein","covid-19","sars-covid-2"],"topics":["Diagnosis"],"weight":1,"_version_":1666138491520548865,"score":173.78067}]}